Edition:
United Kingdom

People: Theratechnologies Inc (TH.TO)

TH.TO on Toronto Stock Exchange

5.42CAD
19 Jul 2019
Change (% chg)

$-0.23 (-4.07%)
Prev Close
$5.65
Open
$5.56
Day's High
$5.65
Day's Low
$5.40
Volume
76,788
Avg. Vol
135,710
52-wk High
$11.45
52-wk Low
$5.17

Svoronos, Dawn 

Ms. Dawn Svoronos is Independent Chairman of the Board of Theratechnologies Inc. Ms. Svoronos (formerly Graham) worked in the commercial side of the business for the multinational pharmaceutical company Merck & Co. Inc., for 23 years, retiring in 2011. From 2009 to 2011, Ms. Svoronos was President of the Europe/Canada region for Merck and from 2006 to 2009 was President of Merck in Canada. Previously held positions with Merck include Vice-President of Asia Pacific and Vice-President of Global Marketing for the Arthritis, Analgesics and Osteoporosis franchise. Ms. Svoronos sits on the Board of Directors of Medivation Inc. in San Francisco and is Chair of the Board of Directors for the Center for Drug Research & Development in Vancouver.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --